Medical Care

Global Long Non-coding RNA Sequencing (lncRNA-seq) Market Research Report 2026

This report delivers a comprehensive overview of the global Long Non-coding RNA Sequencing (lncRNA-seq) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Long Non-coding RNA Sequencing (lncRNA-seq). The Long Non-coding RNA Sequencing (lncRNA-seq) market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Long Non-coding RNA Sequencing (lncRNA-seq) market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Long Non-coding RNA Sequencing (lncRNA-seq) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Aksomics
Anshengda
BGI
Annuoyouda Gene Technology
LC Sciences
Creative Biolabs
Eurofins Scientific
CD Genomics
Novogene
Beijing Compson Biotechnology Co., Ltd.
Biomark Biotechnology
BD
10x Genomics
Majorbio
QIAGEN
Roche
Segment by Type
Equipment Supplies
Service
Segment by Application
Developmental Biology
Oncology
Neuroscience
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Long Non-coding RNA Sequencing (lncRNA-seq) companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Long Non-coding RNA Sequencing (lncRNA-seq) Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Equipment Supplies
1.2.3 Service
1.3 Market by Application
1.3.1 Global Long Non-coding RNA Sequencing (lncRNA-seq) Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Developmental Biology
1.3.3 Oncology
1.3.4 Neuroscience
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Long Non-coding RNA Sequencing (lncRNA-seq) Market Perspective (2021–2032)
2.2 Global Long Non-coding RNA Sequencing (lncRNA-seq) Growth Trends by Region
2.2.1 Global Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Long Non-coding RNA Sequencing (lncRNA-seq) Historic Market Size by Region (2021–2026)
2.2.3 Long Non-coding RNA Sequencing (lncRNA-seq) Forecasted Market Size by Region (2027–2032)
2.3 Long Non-coding RNA Sequencing (lncRNA-seq) Market Dynamics
2.3.1 Long Non-coding RNA Sequencing (lncRNA-seq) Industry Trends
2.3.2 Long Non-coding RNA Sequencing (lncRNA-seq) Market Drivers
2.3.3 Long Non-coding RNA Sequencing (lncRNA-seq) Market Challenges
2.3.4 Long Non-coding RNA Sequencing (lncRNA-seq) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Long Non-coding RNA Sequencing (lncRNA-seq) Players by Revenue
3.1.1 Global Top Long Non-coding RNA Sequencing (lncRNA-seq) Players by Revenue (2021–2026)
3.1.2 Global Long Non-coding RNA Sequencing (lncRNA-seq) Revenue Market Share by Players (2021–2026)
3.2 Global Top Long Non-coding RNA Sequencing (lncRNA-seq) Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Long Non-coding RNA Sequencing (lncRNA-seq) Revenue
3.4 Global Long Non-coding RNA Sequencing (lncRNA-seq) Market Concentration Ratio
3.4.1 Global Long Non-coding RNA Sequencing (lncRNA-seq) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Long Non-coding RNA Sequencing (lncRNA-seq) Revenue in 2025
3.5 Global Key Players of Long Non-coding RNA Sequencing (lncRNA-seq) Head Offices and Areas Served
3.6 Global Key Players of Long Non-coding RNA Sequencing (lncRNA-seq), Products and Applications
3.7 Global Key Players of Long Non-coding RNA Sequencing (lncRNA-seq), Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Long Non-coding RNA Sequencing (lncRNA-seq) Breakdown Data by Type
4.1 Global Long Non-coding RNA Sequencing (lncRNA-seq) Historic Market Size by Type (2021–2026)
4.2 Global Long Non-coding RNA Sequencing (lncRNA-seq) Forecasted Market Size by Type (2027–2032)
5 Long Non-coding RNA Sequencing (lncRNA-seq) Breakdown Data by Application
5.1 Global Long Non-coding RNA Sequencing (lncRNA-seq) Historic Market Size by Application (2021–2026)
5.2 Global Long Non-coding RNA Sequencing (lncRNA-seq) Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Long Non-coding RNA Sequencing (lncRNA-seq) Market Size (2021–2032)
6.2 North America Long Non-coding RNA Sequencing (lncRNA-seq) Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Country (2021–2026)
6.4 North America Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Long Non-coding RNA Sequencing (lncRNA-seq) Market Size (2021–2032)
7.2 Europe Long Non-coding RNA Sequencing (lncRNA-seq) Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Country (2021–2026)
7.4 Europe Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Long Non-coding RNA Sequencing (lncRNA-seq) Market Size (2021–2032)
8.2 Asia-Pacific Long Non-coding RNA Sequencing (lncRNA-seq) Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Region (2021–2026)
8.4 Asia-Pacific Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Long Non-coding RNA Sequencing (lncRNA-seq) Market Size (2021–2032)
9.2 Latin America Long Non-coding RNA Sequencing (lncRNA-seq) Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Country (2021–2026)
9.4 Latin America Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Long Non-coding RNA Sequencing (lncRNA-seq) Market Size (2021–2032)
10.2 Middle East & Africa Long Non-coding RNA Sequencing (lncRNA-seq) Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Country (2021–2026)
10.4 Middle East & Africa Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aksomics
11.1.1 Aksomics Company Details
11.1.2 Aksomics Business Overview
11.1.3 Aksomics Long Non-coding RNA Sequencing (lncRNA-seq) Introduction
11.1.4 Aksomics Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2021–2026)
11.1.5 Aksomics Recent Development
11.2 Anshengda
11.2.1 Anshengda Company Details
11.2.2 Anshengda Business Overview
11.2.3 Anshengda Long Non-coding RNA Sequencing (lncRNA-seq) Introduction
11.2.4 Anshengda Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2021–2026)
11.2.5 Anshengda Recent Development
11.3 BGI
11.3.1 BGI Company Details
11.3.2 BGI Business Overview
11.3.3 BGI Long Non-coding RNA Sequencing (lncRNA-seq) Introduction
11.3.4 BGI Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2021–2026)
11.3.5 BGI Recent Development
11.4 Annuoyouda Gene Technology
11.4.1 Annuoyouda Gene Technology Company Details
11.4.2 Annuoyouda Gene Technology Business Overview
11.4.3 Annuoyouda Gene Technology Long Non-coding RNA Sequencing (lncRNA-seq) Introduction
11.4.4 Annuoyouda Gene Technology Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2021–2026)
11.4.5 Annuoyouda Gene Technology Recent Development
11.5 LC Sciences
11.5.1 LC Sciences Company Details
11.5.2 LC Sciences Business Overview
11.5.3 LC Sciences Long Non-coding RNA Sequencing (lncRNA-seq) Introduction
11.5.4 LC Sciences Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2021–2026)
11.5.5 LC Sciences Recent Development
11.6 Creative Biolabs
11.6.1 Creative Biolabs Company Details
11.6.2 Creative Biolabs Business Overview
11.6.3 Creative Biolabs Long Non-coding RNA Sequencing (lncRNA-seq) Introduction
11.6.4 Creative Biolabs Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2021–2026)
11.6.5 Creative Biolabs Recent Development
11.7 Eurofins Scientific
11.7.1 Eurofins Scientific Company Details
11.7.2 Eurofins Scientific Business Overview
11.7.3 Eurofins Scientific Long Non-coding RNA Sequencing (lncRNA-seq) Introduction
11.7.4 Eurofins Scientific Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2021–2026)
11.7.5 Eurofins Scientific Recent Development
11.8 CD Genomics
11.8.1 CD Genomics Company Details
11.8.2 CD Genomics Business Overview
11.8.3 CD Genomics Long Non-coding RNA Sequencing (lncRNA-seq) Introduction
11.8.4 CD Genomics Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2021–2026)
11.8.5 CD Genomics Recent Development
11.9 Novogene
11.9.1 Novogene Company Details
11.9.2 Novogene Business Overview
11.9.3 Novogene Long Non-coding RNA Sequencing (lncRNA-seq) Introduction
11.9.4 Novogene Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2021–2026)
11.9.5 Novogene Recent Development
11.10 Beijing Compson Biotechnology Co., Ltd.
11.10.1 Beijing Compson Biotechnology Co., Ltd. Company Details
11.10.2 Beijing Compson Biotechnology Co., Ltd. Business Overview
11.10.3 Beijing Compson Biotechnology Co., Ltd. Long Non-coding RNA Sequencing (lncRNA-seq) Introduction
11.10.4 Beijing Compson Biotechnology Co., Ltd. Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2021–2026)
11.10.5 Beijing Compson Biotechnology Co., Ltd. Recent Development
11.11 Biomark Biotechnology
11.11.1 Biomark Biotechnology Company Details
11.11.2 Biomark Biotechnology Business Overview
11.11.3 Biomark Biotechnology Long Non-coding RNA Sequencing (lncRNA-seq) Introduction
11.11.4 Biomark Biotechnology Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2021–2026)
11.11.5 Biomark Biotechnology Recent Development
11.12 BD
11.12.1 BD Company Details
11.12.2 BD Business Overview
11.12.3 BD Long Non-coding RNA Sequencing (lncRNA-seq) Introduction
11.12.4 BD Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2021–2026)
11.12.5 BD Recent Development
11.13 10x Genomics
11.13.1 10x Genomics Company Details
11.13.2 10x Genomics Business Overview
11.13.3 10x Genomics Long Non-coding RNA Sequencing (lncRNA-seq) Introduction
11.13.4 10x Genomics Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2021–2026)
11.13.5 10x Genomics Recent Development
11.14 Majorbio
11.14.1 Majorbio Company Details
11.14.2 Majorbio Business Overview
11.14.3 Majorbio Long Non-coding RNA Sequencing (lncRNA-seq) Introduction
11.14.4 Majorbio Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2021–2026)
11.14.5 Majorbio Recent Development
11.15 QIAGEN
11.15.1 QIAGEN Company Details
11.15.2 QIAGEN Business Overview
11.15.3 QIAGEN Long Non-coding RNA Sequencing (lncRNA-seq) Introduction
11.15.4 QIAGEN Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2021–2026)
11.15.5 QIAGEN Recent Development
11.16 Roche
11.16.1 Roche Company Details
11.16.2 Roche Business Overview
11.16.3 Roche Long Non-coding RNA Sequencing (lncRNA-seq) Introduction
11.16.4 Roche Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2021–2026)
11.16.5 Roche Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Long Non-coding RNA Sequencing (lncRNA-seq) Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Equipment Supplies
Table 3. Key Players of Service
Table 4. Global Long Non-coding RNA Sequencing (lncRNA-seq) Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Region (US$ Million), 2021–2026
Table 7. Global Long Non-coding RNA Sequencing (lncRNA-seq) Market Share by Region (2021–2026)
Table 8. Global Long Non-coding RNA Sequencing (lncRNA-seq) Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Long Non-coding RNA Sequencing (lncRNA-seq) Market Share by Region (2027–2032)
Table 10. Long Non-coding RNA Sequencing (lncRNA-seq) Market Trends
Table 11. Long Non-coding RNA Sequencing (lncRNA-seq) Market Drivers
Table 12. Long Non-coding RNA Sequencing (lncRNA-seq) Market Challenges
Table 13. Long Non-coding RNA Sequencing (lncRNA-seq) Market Restraints
Table 14. Global Long Non-coding RNA Sequencing (lncRNA-seq) Revenue by Players (US$ Million), 2021–2026
Table 15. Global Long Non-coding RNA Sequencing (lncRNA-seq) Market Share by Players (2021–2026)
Table 16. Global Top Long Non-coding RNA Sequencing (lncRNA-seq) Players by Tier (Tier 1, Tier 2, and Tier 3), based on Long Non-coding RNA Sequencing (lncRNA-seq) Revenue, 2025
Table 17. Ranking of Global Top Long Non-coding RNA Sequencing (lncRNA-seq) Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Long Non-coding RNA Sequencing (lncRNA-seq) Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Long Non-coding RNA Sequencing (lncRNA-seq), Headquarters and Area Served
Table 20. Global Key Players of Long Non-coding RNA Sequencing (lncRNA-seq), Products and Applications
Table 21. Global Key Players of Long Non-coding RNA Sequencing (lncRNA-seq), Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Type (US$ Million), 2021–2026
Table 24. Global Long Non-coding RNA Sequencing (lncRNA-seq) Revenue Market Share by Type (2021–2026)
Table 25. Global Long Non-coding RNA Sequencing (lncRNA-seq) Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Long Non-coding RNA Sequencing (lncRNA-seq) Revenue Market Share by Type (2027–2032)
Table 27. Global Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Application (US$ Million), 2021–2026
Table 28. Global Long Non-coding RNA Sequencing (lncRNA-seq) Revenue Market Share by Application (2021–2026)
Table 29. Global Long Non-coding RNA Sequencing (lncRNA-seq) Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Long Non-coding RNA Sequencing (lncRNA-seq) Revenue Market Share by Application (2027–2032)
Table 31. North America Long Non-coding RNA Sequencing (lncRNA-seq) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Country (US$ Million), 2021–2026
Table 33. North America Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Long Non-coding RNA Sequencing (lncRNA-seq) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Long Non-coding RNA Sequencing (lncRNA-seq) Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Long Non-coding RNA Sequencing (lncRNA-seq) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Long Non-coding RNA Sequencing (lncRNA-seq) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Country (US$ Million), 2027–2032
Table 46. Aksomics Company Details
Table 47. Aksomics Business Overview
Table 48. Aksomics Long Non-coding RNA Sequencing (lncRNA-seq) Product
Table 49. Aksomics Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (US$ Million), 2021–2026
Table 50. Aksomics Recent Development
Table 51. Anshengda Company Details
Table 52. Anshengda Business Overview
Table 53. Anshengda Long Non-coding RNA Sequencing (lncRNA-seq) Product
Table 54. Anshengda Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (US$ Million), 2021–2026
Table 55. Anshengda Recent Development
Table 56. BGI Company Details
Table 57. BGI Business Overview
Table 58. BGI Long Non-coding RNA Sequencing (lncRNA-seq) Product
Table 59. BGI Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (US$ Million), 2021–2026
Table 60. BGI Recent Development
Table 61. Annuoyouda Gene Technology Company Details
Table 62. Annuoyouda Gene Technology Business Overview
Table 63. Annuoyouda Gene Technology Long Non-coding RNA Sequencing (lncRNA-seq) Product
Table 64. Annuoyouda Gene Technology Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (US$ Million), 2021–2026
Table 65. Annuoyouda Gene Technology Recent Development
Table 66. LC Sciences Company Details
Table 67. LC Sciences Business Overview
Table 68. LC Sciences Long Non-coding RNA Sequencing (lncRNA-seq) Product
Table 69. LC Sciences Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (US$ Million), 2021–2026
Table 70. LC Sciences Recent Development
Table 71. Creative Biolabs Company Details
Table 72. Creative Biolabs Business Overview
Table 73. Creative Biolabs Long Non-coding RNA Sequencing (lncRNA-seq) Product
Table 74. Creative Biolabs Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (US$ Million), 2021–2026
Table 75. Creative Biolabs Recent Development
Table 76. Eurofins Scientific Company Details
Table 77. Eurofins Scientific Business Overview
Table 78. Eurofins Scientific Long Non-coding RNA Sequencing (lncRNA-seq) Product
Table 79. Eurofins Scientific Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (US$ Million), 2021–2026
Table 80. Eurofins Scientific Recent Development
Table 81. CD Genomics Company Details
Table 82. CD Genomics Business Overview
Table 83. CD Genomics Long Non-coding RNA Sequencing (lncRNA-seq) Product
Table 84. CD Genomics Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (US$ Million), 2021–2026
Table 85. CD Genomics Recent Development
Table 86. Novogene Company Details
Table 87. Novogene Business Overview
Table 88. Novogene Long Non-coding RNA Sequencing (lncRNA-seq) Product
Table 89. Novogene Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (US$ Million), 2021–2026
Table 90. Novogene Recent Development
Table 91. Beijing Compson Biotechnology Co., Ltd. Company Details
Table 92. Beijing Compson Biotechnology Co., Ltd. Business Overview
Table 93. Beijing Compson Biotechnology Co., Ltd. Long Non-coding RNA Sequencing (lncRNA-seq) Product
Table 94. Beijing Compson Biotechnology Co., Ltd. Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (US$ Million), 2021–2026
Table 95. Beijing Compson Biotechnology Co., Ltd. Recent Development
Table 96. Biomark Biotechnology Company Details
Table 97. Biomark Biotechnology Business Overview
Table 98. Biomark Biotechnology Long Non-coding RNA Sequencing (lncRNA-seq) Product
Table 99. Biomark Biotechnology Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (US$ Million), 2021–2026
Table 100. Biomark Biotechnology Recent Development
Table 101. BD Company Details
Table 102. BD Business Overview
Table 103. BD Long Non-coding RNA Sequencing (lncRNA-seq) Product
Table 104. BD Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (US$ Million), 2021–2026
Table 105. BD Recent Development
Table 106. 10x Genomics Company Details
Table 107. 10x Genomics Business Overview
Table 108. 10x Genomics Long Non-coding RNA Sequencing (lncRNA-seq) Product
Table 109. 10x Genomics Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (US$ Million), 2021–2026
Table 110. 10x Genomics Recent Development
Table 111. Majorbio Company Details
Table 112. Majorbio Business Overview
Table 113. Majorbio Long Non-coding RNA Sequencing (lncRNA-seq) Product
Table 114. Majorbio Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (US$ Million), 2021–2026
Table 115. Majorbio Recent Development
Table 116. QIAGEN Company Details
Table 117. QIAGEN Business Overview
Table 118. QIAGEN Long Non-coding RNA Sequencing (lncRNA-seq) Product
Table 119. QIAGEN Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (US$ Million), 2021–2026
Table 120. QIAGEN Recent Development
Table 121. Roche Company Details
Table 122. Roche Business Overview
Table 123. Roche Long Non-coding RNA Sequencing (lncRNA-seq) Product
Table 124. Roche Revenue in Long Non-coding RNA Sequencing (lncRNA-seq) Business (US$ Million), 2021–2026
Table 125. Roche Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
Table 129. Authors List of This Report


List of Figures
Figure 1. Long Non-coding RNA Sequencing (lncRNA-seq) Picture
Figure 2. Global Long Non-coding RNA Sequencing (lncRNA-seq) Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Long Non-coding RNA Sequencing (lncRNA-seq) Market Share by Type: 2025 vs 2032
Figure 4. Equipment Supplies Features
Figure 5. Service Features
Figure 6. Global Long Non-coding RNA Sequencing (lncRNA-seq) Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Long Non-coding RNA Sequencing (lncRNA-seq) Market Share by Application: 2025 vs 2032
Figure 8. Developmental Biology Case Studies
Figure 9. Oncology Case Studies
Figure 10. Neuroscience Case Studies
Figure 11. Other Case Studies
Figure 12. Long Non-coding RNA Sequencing (lncRNA-seq) Report Years Considered
Figure 13. Global Long Non-coding RNA Sequencing (lncRNA-seq) Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global Long Non-coding RNA Sequencing (lncRNA-seq) Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Long Non-coding RNA Sequencing (lncRNA-seq) Market Share by Region: 2025 vs 2032
Figure 16. Global Long Non-coding RNA Sequencing (lncRNA-seq) Market Share by Players in 2025
Figure 17. Global Long Non-coding RNA Sequencing (lncRNA-seq) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Long Non-coding RNA Sequencing (lncRNA-seq) Revenue in 2025
Figure 19. North America Long Non-coding RNA Sequencing (lncRNA-seq) Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America Long Non-coding RNA Sequencing (lncRNA-seq) Market Share by Country (2021–2032)
Figure 21. United States Long Non-coding RNA Sequencing (lncRNA-seq) Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada Long Non-coding RNA Sequencing (lncRNA-seq) Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Long Non-coding RNA Sequencing (lncRNA-seq) Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Long Non-coding RNA Sequencing (lncRNA-seq) Market Share by Country (2021–2032)
Figure 25. Germany Long Non-coding RNA Sequencing (lncRNA-seq) Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France Long Non-coding RNA Sequencing (lncRNA-seq) Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. Long Non-coding RNA Sequencing (lncRNA-seq) Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy Long Non-coding RNA Sequencing (lncRNA-seq) Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia Long Non-coding RNA Sequencing (lncRNA-seq) Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland Long Non-coding RNA Sequencing (lncRNA-seq) Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Long Non-coding RNA Sequencing (lncRNA-seq) Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Long Non-coding RNA Sequencing (lncRNA-seq) Market Share by Region (2021–2032)
Figure 33. China Long Non-coding RNA Sequencing (lncRNA-seq) Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan Long Non-coding RNA Sequencing (lncRNA-seq) Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea Long Non-coding RNA Sequencing (lncRNA-seq) Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia Long Non-coding RNA Sequencing (lncRNA-seq) Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India Long Non-coding RNA Sequencing (lncRNA-seq) Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand Long Non-coding RNA Sequencing (lncRNA-seq) Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Long Non-coding RNA Sequencing (lncRNA-seq) Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Long Non-coding RNA Sequencing (lncRNA-seq) Market Share by Country (2021–2032)
Figure 41. Mexico Long Non-coding RNA Sequencing (lncRNA-seq) Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil Long Non-coding RNA Sequencing (lncRNA-seq) Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Long Non-coding RNA Sequencing (lncRNA-seq) Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Long Non-coding RNA Sequencing (lncRNA-seq) Market Share by Country (2021–2032)
Figure 45. Israel Long Non-coding RNA Sequencing (lncRNA-seq) Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia Long Non-coding RNA Sequencing (lncRNA-seq) Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE Long Non-coding RNA Sequencing (lncRNA-seq) Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Aksomics Revenue Growth Rate in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2021–2026)
Figure 49. Anshengda Revenue Growth Rate in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2021–2026)
Figure 50. BGI Revenue Growth Rate in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2021–2026)
Figure 51. Annuoyouda Gene Technology Revenue Growth Rate in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2021–2026)
Figure 52. LC Sciences Revenue Growth Rate in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2021–2026)
Figure 53. Creative Biolabs Revenue Growth Rate in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2021–2026)
Figure 54. Eurofins Scientific Revenue Growth Rate in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2021–2026)
Figure 55. CD Genomics Revenue Growth Rate in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2021–2026)
Figure 56. Novogene Revenue Growth Rate in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2021–2026)
Figure 57. Beijing Compson Biotechnology Co., Ltd. Revenue Growth Rate in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2021–2026)
Figure 58. Biomark Biotechnology Revenue Growth Rate in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2021–2026)
Figure 59. BD Revenue Growth Rate in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2021–2026)
Figure 60. 10x Genomics Revenue Growth Rate in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2021–2026)
Figure 61. Majorbio Revenue Growth Rate in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2021–2026)
Figure 62. QIAGEN Revenue Growth Rate in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2021–2026)
Figure 63. Roche Revenue Growth Rate in Long Non-coding RNA Sequencing (lncRNA-seq) Business (2021–2026)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies